SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,886.00 50.22
( 0.07%)

Global Indices

Nasdaq

52,223.83 255.58
(0.49%)

Dow Jones

7,434.43 1.45
(0.02%)

Hang Seng

64,889.11 277.96
(0.43%)

Nikkei 225

10,802.25 66.02
(0.61%)

Forex

USD-INR

96.67 0.19
(0.20%)

EUR-INR

110.18 0.12
(0.10%)

GBP-INR

129.04 -0.01
(0.00%)

JPY-INR

0.59 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

509079

INE742B01025

66.2307167

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUFICBIO

60.56

3826.28

EPS(TTM)

Face Value()

Div & Yield %

6.3

0.03

Back

aditya birla capital ltd

Board of Coromandel International recommends Final Dividend

May 07,2026

Coromandel International announced that the Board of Directors of the Company at its meeting held on 07 May 2026, has recommended a Final Dividend of Rs.2 per share (i.e.200%), subject to the approval of the shareholders.

76,886.00 50.22 ( 0.07%)

52,223.83 255.58 (0.49%)

7,434.43 1.45 (0.02%)

64,889.11 277.96 (0.43%)

10,802.25 66.02 (0.61%)

96.67 0.19 (0.20%)

110.18 0.12 (0.10%)

129.04 -0.01 (0.00%)

0.59 0.00 (-0.04%)